Elisa R. Port, MD, FACS, Named Chief of Breast Surgery at Mount Sinai School of Medicine
Renowned surgeon Elisa R. Port, MD, FACS, returns as Chief of Breast Surgery and Co-Director of the Dubin Breast Center.
Renowned surgeon Elisa R. Port, MD, FACS, is returning to The Mount Sinai Medical Center as Chief of Breast Surgery and Co-Director of the Dubin Breast Center. Her appointment becomes effective on April 26.
“The Dubin Center is a comprehensive, highly integrated program, and we wanted the best physicians in breast cancer clinical are and research to lead the team,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. “We’re pleased to have someone of Dr. Port’s caliber join our distinguished center.”
Dr. Port is a leading expert in sentinel-node biopsy, a procedure that allows physicians to determine the patient’s breast cancer stage, and the use of breast MRI in high-risk patients. Widely published on these topics and more, Dr. Port’s research has been featured in numerous journals, including the Journal of the American College of Surgeons, Annals of Surgery and Cancer Research.
Through a grant from the Susan G. Komen Foundation, Dr. Port researched positron emission tomography (PET), an imaging procedure that produces advanced 3-D images of the body, and its use in pre-operative assessment of breast cancer. She is also conducting, through funding from the National Cancer Institute, a Phase I study on the inhibition of the enzymes COX-2 and aromatase in breast cancer.
In addition to her research, Dr. Port is also a member of several professional associations, including the American Society of Clinical Oncology, the American Society of Breast Diseases, the Society of Surgical Oncology, and the American College of Surgeons, for whom she is a Fellow.
“Since graduating from Mount Sinai School of Medicine, Dr. Port has conducted seminal research on breast cancer and remained committed to seamless patient care,” said Michael L. Marin, M.D., F.A.C.S., The Julius H. Jacobson II, M.D. Professor of Surgery, and Chairman, Department of Surgery, Mount Sinai School of Medicine.“With Dr. Port at the helm, Mount Sinai will further solidify its reputation of providing top-rated breast cancer care.”
After receiving her medical degree from Mount Sinai School of Medicine in 1992, Dr. Port was a general surgery resident at Cedars-Sinai Medical Center in Los Angeles until 1994. She then joined Memorial Sloan-Kettering Cancer Center for a breast cancer surgery research fellowship, and then continued on to Long Island Jewish Medical Center where she had completed a general surgery residency. In 1999 she joined Memorial Sloan-Kettering Cancer Center and Memorial Hospital for Cancer and Allied Diseases, where she remained as an Associate Member and Associate Attending Surgeon until her Mount Sinai appointment.
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses The Mount Sinai Hospital and Mount Sinai School of Medicine. The Mount Sinai Hospital is one of the nation’s oldest, largest and most-respected voluntary hospitals. Founded in 1852, Mount Sinai today is a 1,171-bed tertiary-care teaching facility that is internationally acclaimed for excellence in clinical care. Last year, nearly 60,000 people were treated at Mount Sinai as inpatients, and there were nearly 450,000 outpatient visits to the Medical Center.
Mount Sinai School of Medicine is internationally recognized as a leader in groundbreaking clinical and basic science research, as well as having an innovative approach to medical education. With a faculty of more than 3,400 in 38 clinical and basic science departments and centers, Mount Sinai ranks among the top 20 medical schools in receipt of National Institute of Health (NIH) grants. For more information, please visit www.mountsinai.org.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system encompassing (with the addition of South Nassau Communities Hospital) eight hospital campuses, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in six other specialties in the 2018-2019 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology and 44th for Ear, Nose, and Throat. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and South Nassau Communities Hospital are ranked regionally.